NO20030649L - Komplekser inneholdende perfluoralkyl med polare radikaler, fremgangsmåterfor fremstilling og anvendelse derav - Google Patents

Komplekser inneholdende perfluoralkyl med polare radikaler, fremgangsmåterfor fremstilling og anvendelse derav

Info

Publication number: NO20030649L
Authority: NO; Norway
Prior art keywords: preparation; methods; complexes containing; containing polar; polar radical
Prior art date: 2000-08-11

Application number

NO20030649A

Other languages

English (en)

Norwegian (no)

Other versions

NO20030649D0 (no

Inventor

Johannes Platzek

Peter Mareski

Ulrich Niedballa

Bernd Raduechel

Hanns-Joachim Weinmann

Bernd Misselwitz

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-11

Filing date

2003-02-10

Publication date

2003-04-11

2003-02-10 Application filed by Schering Ag filed Critical Schering Ag

2003-02-10 Publication of NO20030649D0 publication Critical patent/NO20030649D0/no

2003-04-11 Publication of NO20030649L publication Critical patent/NO20030649L/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F19/00—Metal compounds according to more than one of main groups C07F1/00 - C07F17/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
- A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
- A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Radiology & Medical Imaging (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20030649A 2000-08-11 2003-02-10 Komplekser inneholdende perfluoralkyl med polare radikaler, fremgangsmåterfor fremstilling og anvendelse derav NO20030649L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10040858A DE10040858C2 (de)	2000-08-11	2000-08-11	Perfluoralkylhaltige Komplexe mit polaren Resten, Verfahren zu deren Herstellung und ihre Verwendung
PCT/EP2001/008500 WO2002013875A2 (fr)	2000-08-11	2001-07-23	Complexes perfluoroalkyles a residus polaires, leur procede de fabrication et leur utilisation

Publications (2)

Publication Number	Publication Date
NO20030649D0 NO20030649D0 (no)	2003-02-10
NO20030649L true NO20030649L (no)	2003-04-11

Family

ID=7653176

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20030649A NO20030649L (no)	2000-08-11	2003-02-10	Komplekser inneholdende perfluoralkyl med polare radikaler, fremgangsmåterfor fremstilling og anvendelse derav

Country Status (30)

Country	Link
EP (1)	EP1307237B9 (fr)
JP (1)	JP2004506026A (fr)
KR (2)	KR20080027397A (fr)
CN (1)	CN1468113A (fr)
AR (1)	AR035342A1 (fr)
AT (1)	ATE359093T1 (fr)
AU (2)	AU7977701A (fr)
BG (1)	BG107541A (fr)
BR (1)	BR0113187A (fr)
CA (1)	CA2419259A1 (fr)
CZ (1)	CZ2003341A3 (fr)
DE (2)	DE10040858C2 (fr)
DK (1)	DK1307237T3 (fr)
EE (1)	EE200300060A (fr)
ES (1)	ES2284671T3 (fr)
HR (1)	HRP20030171A2 (fr)
HU (1)	HUP0300769A3 (fr)
IL (1)	IL154329A0 (fr)
MX (1)	MXPA03001286A (fr)
NO (1)	NO20030649L (fr)
NZ (1)	NZ524080A (fr)
PL (1)	PL365367A1 (fr)
PT (1)	PT1307237E (fr)
RU (1)	RU2289579C2 (fr)
SK (1)	SK286239B6 (fr)
UA (1)	UA74004C2 (fr)
UY (1)	UY26873A1 (fr)
WO (1)	WO2002013875A2 (fr)
YU (1)	YU10503A (fr)
ZA (1)	ZA200301947B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10231799B4 (de) *	2002-07-10	2006-10-05	Schering Ag	Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Intravasalen Thromben
US7344704B2 (en)	2002-07-10	2008-03-18	Schering Ag	Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi
DE102005033903B4 (de) *	2005-07-15	2007-08-09	Bayer Schering Pharma Ag	Perfluoralkylhaltige Komplexe, Verfahren zu deren Herstellung, sowie deren Verwendung und diese enthaltende pharmazeutische Mittel
DE102005033902B3 (de) *	2005-07-15	2007-04-05	Schering Ag	Perfluoralkylhaltige Komplexe, Verfahren zu deren Herstellung, sowie deren Verwendung und diese enthaltende pharmazeutische Mittel
CA2615434A1 (fr) *	2005-07-15	2007-01-25	Bayer Schering Pharma Aktiengesellschaft	Complexes perfluoro-alkyles, leur procede de production et leur utilisation
DE102006049821A1 (de) *	2006-10-18	2008-04-24	Bayer Schering Pharma Aktiengesellschaft	Metallchelate mit perfluoriertem PEG-Rest, Verfahren zu deren Herstellung, sowie deren Verwendung
DE102007015598A1 (de) *	2007-03-29	2008-10-02	Heinrich-Heine-Universität Düsseldorf	Verwendung von fluorhaltigen Verbindungen zu Diagnosezwecken mit Hilfe bildgebender Verfahren
EP3101012A1 (fr)	2015-06-04	2016-12-07	Bayer Pharma Aktiengesellschaft	Nouveaux composés de chélate de gadolinium pour une utilisation dans l'imagerie par résonance magnétique
US10975060B2 (en)	2016-11-28	2021-04-13	Bayer Pharma Aktiengesellschaft	High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging
RU2681319C1 (ru) *	2017-10-27	2019-03-06	Федеральное государственное бюджетное образовательное учреждение высшего образования "Российский экономический университет имени Г.В. Плеханова" (ФГБОУ ВО "РЭУ им. Г.В. Плеханова")	Ультраволокнистый биополимерный материал с бактерицидным эффектом
PE20211471A1 (es)	2018-11-23	2021-08-05	Bayer Ag	Formulacion de medios de contraste y proceso para prepararlos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4317588C2 (de) *	1993-05-24	1998-04-16	Schering Ag	Fluorhaltige makrocyclische Metallkomplexe, Verfahren zu ihrer Herstellung, sowie ihre Verwendung
DE19603033A1 (de) *	1996-01-19	1997-07-24	Schering Ag	Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19608278A1 (de) *	1996-02-23	1997-08-28	Schering Ag	Pharmazeutische Mittel enthaltend perfluoralkylhaltige Metallkomplexe, und ihre Verwendung in der Tumortherapie und interventioniellen Radiologie
DE19729013A1 (de) *	1997-07-03	1999-02-04	Schering Ag	Oligomere, perfluoralkylhaltige Verbindungen, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19744004C1 (de) *	1997-09-26	1999-07-22	Schering Ag	Lipophile Metall-Komplexe für Nekrose und Infarkt-Imaging

2000
- 2000-08-11 DE DE10040858A patent/DE10040858C2/de not_active Expired - Fee Related
2001
- 2001-07-23 MX MXPA03001286A patent/MXPA03001286A/es not_active Application Discontinuation
- 2001-07-23 AU AU7977701A patent/AU7977701A/xx active Pending
- 2001-07-23 SK SK155-2003A patent/SK286239B6/sk unknown
- 2001-07-23 YU YU10503A patent/YU10503A/sh unknown
- 2001-07-23 WO PCT/EP2001/008500 patent/WO2002013875A2/fr active IP Right Grant
- 2001-07-23 IL IL15432901A patent/IL154329A0/xx not_active IP Right Cessation
- 2001-07-23 DK DK01958005T patent/DK1307237T3/da active
- 2001-07-23 JP JP2002519013A patent/JP2004506026A/ja not_active Withdrawn
- 2001-07-23 EP EP01958005A patent/EP1307237B9/fr not_active Expired - Lifetime
- 2001-07-23 KR KR1020087003857A patent/KR20080027397A/ko not_active Ceased
- 2001-07-23 ES ES01958005T patent/ES2284671T3/es not_active Expired - Lifetime
- 2001-07-23 HU HU0300769A patent/HUP0300769A3/hu unknown
- 2001-07-23 RU RU2003105813/04A patent/RU2289579C2/ru not_active IP Right Cessation
- 2001-07-23 CZ CZ2003341A patent/CZ2003341A3/cs unknown
- 2001-07-23 DE DE50112336T patent/DE50112336D1/de not_active Expired - Fee Related
- 2001-07-23 EE EEP200300060A patent/EE200300060A/xx unknown
- 2001-07-23 UA UA2003032068A patent/UA74004C2/uk unknown
- 2001-07-23 AU AU2001279777A patent/AU2001279777B2/en not_active Ceased
- 2001-07-23 CN CNA018170765A patent/CN1468113A/zh active Pending
- 2001-07-23 NZ NZ524080A patent/NZ524080A/en unknown
- 2001-07-23 PL PL01365367A patent/PL365367A1/xx unknown
- 2001-07-23 CA CA002419259A patent/CA2419259A1/fr not_active Abandoned
- 2001-07-23 BR BR0113187-7A patent/BR0113187A/pt not_active IP Right Cessation
- 2001-07-23 PT PT01958005T patent/PT1307237E/pt unknown
- 2001-07-23 KR KR10-2003-7001937A patent/KR20030022381A/ko not_active Ceased
- 2001-07-23 AT AT01958005T patent/ATE359093T1/de not_active IP Right Cessation
- 2001-08-07 UY UY26873A patent/UY26873A1/es not_active Application Discontinuation
- 2001-08-10 AR ARP010103832A patent/AR035342A1/es unknown
2003
- 2003-02-07 BG BG107541A patent/BG107541A/bg unknown
- 2003-02-10 NO NO20030649A patent/NO20030649L/no not_active Application Discontinuation
- 2003-03-10 ZA ZA200301947A patent/ZA200301947B/en unknown
- 2003-03-10 HR HR20030171A patent/HRP20030171A2/hr not_active Application Discontinuation

Also Published As

Publication number	Publication date
DK1307237T3 (da)	2007-07-02
SK1552003A3 (en)	2003-09-11
ZA200301947B (en)	2004-06-25
KR20030022381A (ko)	2003-03-15
PT1307237E (pt)	2007-07-02
ATE359093T1 (de)	2007-05-15
NZ524080A (en)	2005-10-28
BR0113187A (pt)	2003-07-01
PL365367A1 (en)	2004-12-27
SK286239B6 (sk)	2008-06-06
HUP0300769A3 (en)	2009-03-02
DE10040858A1 (de)	2002-03-28
EP1307237B9 (fr)	2008-01-09
RU2289579C2 (ru)	2006-12-20
EP1307237B1 (fr)	2007-04-11
AU2001279777B2 (en)	2006-08-31
AU7977701A (en)	2002-02-25
WO2002013875A3 (fr)	2002-08-22
BG107541A (bg)	2004-01-30
WO2002013875A2 (fr)	2002-02-21
HRP20030171A2 (en)	2004-06-30
HUP0300769A2 (hu)	2003-09-29
EP1307237A2 (fr)	2003-05-07
MXPA03001286A (es)	2004-04-20
EE200300060A (et)	2004-12-15
CA2419259A1 (fr)	2002-02-21
DE10040858C2 (de)	2003-12-18
ES2284671T3 (es)	2007-11-16
YU10503A (sh)	2006-08-17
JP2004506026A (ja)	2004-02-26
UA74004C2 (en)	2005-10-17
NO20030649D0 (no)	2003-02-10
UY26873A1 (es)	2002-03-22
CN1468113A (zh)	2004-01-14
DE50112336D1 (de)	2007-05-24
CZ2003341A3 (cs)	2003-05-14
IL154329A0 (en)	2003-09-17
AR035342A1 (es)	2004-05-12
KR20080027397A (ko)	2008-03-26

Legal Events

Date	Code	Title	Description
2009-02-23	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
DK1417175T3 (da)	2013-10-28	Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
MXPA03006010A (es)	2003-09-10	Derivados de arilamina sustituida y metodos de uso.
MXPA03006260A (es)	2003-09-22	Derivados de amina sustituidos y metodos de uso.
IS6934A (is)	2003-08-29	Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar
IS7079A (is)	2003-12-15	Fenýlsúlfónýl-1,3-díhýdró-2H-indól-2-ón afleiður,framleiðsla þeirra og notkun í meðferðarskyni
DK1423376T3 (da)	2010-06-28	Bicyklisk forbindelse, fremstilling og anvendelse deraf
NO20035366D0 (no)	2003-12-02	Benzoylsulfonamider og sulfonylbenzamidiner for anvendelse som antitumormidler
NO20041216L (no)	2004-05-05	Imidazol-4-karboksamidderivater, fremstilling og anvendelse derav for behandling av overvekt
IS7041A (is)	2003-11-17	5-HT viðtakabindlar og notkun þeirra
IS6661A (is)	2002-12-19	Bensimídasólafleiður, framleiðsla þeirra og meðferðarleg notkun
IS8422A (is)	2006-04-21	Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun þeirra
IS5756A (is)	2000-12-08	Notkun hreinljósvirks (+) -norkisapríðs við meðhöndlun á öndunarstöðvun, lotugræðgi og öðrum meinum
DK1392292T3 (da)	2006-05-29	Pyranoindazoler og deres anvendelse til behandling af glaukom
NO20033854L (no)	2003-10-28	N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
DK1537096T3 (da)	2009-02-02	Derivater af dioxan-2-alkylcarbamater, fremstilling og terapeutisk anvendelse heraf
NO20030649D0 (no)	2003-02-10	Komplekser inneholdende perfluoralkyl med polare radikaler, fremgangsmåterfor fremstilling og anvendelse derav
DK1417189T3 (da)	2006-05-08	Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
IS8219A (is)	2006-01-04	Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun
NO20033506D0 (no)	2003-08-07	Parasittdrepende preparater og fremgangsmåter for anvendelse
NO20011026D0 (no)	2001-02-28	Matvare og fremgangsmÕte for fremstilling derav
DK1334106T3 (da)	2006-09-18	Imidazolderivater, fremstillingsmetoder deraf og anvendelse deraf
DK1556382T3 (da)	2008-10-06	3-Phenylpyridoindolderivater, fremstilling og terapeutisk anvendelse deraf
EP1392280A4 (fr)	2005-11-30	Ethers arylsulfonamide et techniques d'utilisation de ces composes
IS2331B (is)	2008-02-15	2-arýlimínó-2,3-díhýdróþíasólafleiður, aðferðir til að framleiða þær og meðferðarfræðileg notkun þeirra
NO20042768L (no)	2004-09-22	IFNAR2 mutanter, deres fremstilling og anvendelse